NFYB and glioblastoma: We found that TMEM60 belongs to the transcriptional regulatory module gene of NFYB, and realized that it may promote cell proliferation and drug resistance and lead to poor prognosis of GBM patients, and by targeting and regulating NFYB, we can make TMEM60 low expression to inhibit proliferation, invasion, and drug resistance of GBM cells, which will be beneficial to the prognosis of patients.